AtriCure (ATRC) Tops Q4 EPS by 9c

AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.09), $0.09 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $88 million versus the consensus estimate of $87.77 million.

GUIDANCE:

AtriCure sees FY2023 revenue of $380-387 million, versus the consensus of $381.7 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Canaccord Reiterates Buy Rating on HubSpot Inc (HUBS)
• Vera Bradley (VRA) Tops Q2 EPS by 10c ; Offers Guidance